As of Feb 12
| -0.03 / -0.71%|
The 1 analysts offering 12-month price forecasts for MediciNova Inc have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +43.20% increase from the last price of 4.19.
The current consensus among 1 polled investment analysts is to Buy stock in MediciNova Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.